MetLife Investment Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-81
| Closed | -$13.2K | – | 2770 |
|
|
2021
Q4 | $13.2K | Sell |
81
-441
| -84% | -$71.8K | ﹤0.01% | 2491 |
|
|
2021
Q3 | $142K | Buy |
522
+236
| +83% | +$64.4K | ﹤0.01% | 2275 |
|
|
2021
Q2 | $113K | Sell |
286
-283
| -50% | -$112K | ﹤0.01% | 2398 |
|
|
2021
Q1 | $307K | Buy |
569
+173
| +44% | +$93.4K | ﹤0.01% | 1799 |
|
|
2020
Q4 | $150K | Sell |
396
-47
| -11% | -$17.8K | ﹤0.01% | 2129 |
|
|
2020
Q3 | $168K | Sell |
443
-209
| -32% | -$79.1K | ﹤0.01% | 1963 |
|
|
2020
Q2 | $321K | Buy |
652
+90
| +16% | +$44.3K | ﹤0.01% | 1622 |
|
|
2020
Q1 | $207K | Buy |
562
+189
| +51% | +$69.5K | ﹤0.01% | 1680 |
|
|
2019
Q4 | $264K | Sell |
373
-127
| -25% | -$89.9K | ﹤0.01% | 1826 |
|
|
2019
Q3 | $321K | Hold |
500
| – | – | ﹤0.01% | 1666 |
|
|
2019
Q2 | $437K | Buy |
500
+71
| +17% | +$62.1K | ﹤0.01% | 1562 |
|
|
2019
Q1 | $248K | Hold |
429
| – | – | ﹤0.01% | 1861 |
|
|
2018
Q4 | $120K | Hold |
429
| – | – | ﹤0.01% | 2203 |
|
|
2018
Q3 | $206K | Sell |
429
-11
| -3% | -$5.28K | ﹤0.01% | 2062 |
|
|
2018
Q2 | $199K | Buy |
440
+192
| +77% | +$86.8K | ﹤0.01% | 1922 |
|
|
2018
Q1 | $146K | Sell |
248
-161
| -39% | -$94.8K | ﹤0.01% | 2050 |
|
|
2017
Q4 | $254K | Buy |
+409
| New | +$254K | ﹤0.01% | 1803 |
|